Research dossier
Clinical research on Vitamin B7
9 trials reviewed across 6 indications.
Strongest evidence
Brittle nail support
Mechanism
Biotin's role in keratin synthesis provides a mechanistic story for nail formation. Studies in horses and pigs (where biotin's hoof-strengthening effect is robust) inspired the human nail trials.
Two open-label studies in the 1990s reported nail-thickness or subjective firmness improvements on 2.5 mg/day biotin in adults with brittle nails. Neither had a placebo control. This is the strongest case biotin has outside genuine deficiency, and even here the evidence is methodologically thin. Worth a 6-month trial in adults with truly brittle, splitting nails — not the universal hair-skin-nail framing.
Specifically for documented brittle nails (onychoschizia), not for general nail aesthetics or growth in healthy adults. Expect months, not weeks.
Trials cited
Biotin for brittle fingernails — scanning electron microscopy
positive · Pilot
Colombo, Gerber et al., 1990, Journal of the American Academy of Dermatologyn=32Uncontrolled study of 32 subjects (10 controls with normal nails, 22 with brittle nails). Treatment group showed a 25% increase in nail thickness on scanning electron microscopy after 6–15 months on 2.5 mg/day biotin. The most-cited evidence for the biotin-and-nails claim — and it has no placebo control.
No placebo arm. Small sample. Open-label. The evidence for biotin and nails comes mostly from this study and Hochman 1993, neither of which is a properly controlled trial.
Brittle nails: response to daily biotin
positive · Pilot
Hochman, Scher, Meyerson, 1993, Cutisn=3535 women with brittle nails on 2.5 mg/day biotin for 6 months. 63% reported subjective improvement. Companion piece to Colombo 1990. Same methodological problems — no placebo control, no objective primary endpoint, no blinding.
Open-label. Subjective endpoint. The two cornerstone biotin-nail trials are both methodologically thin. The strongest fair conclusion: biotin may help genuinely brittle nails in some adults, but the evidence is far weaker than the marketing suggests.
Glycemic control in type 2 diabetes
Mechanism
Biotin upregulates glucokinase and influences insulin signaling pathways in animal models. Mechanistic plausibility exists; clinical magnitude is small.
Biotin alone has shown modest reductions in fasting glucose and triglycerides in pooled type 2 diabetes trials, with no significant HbA1c effect on its own. The Albarracin chromium-plus-biotin trial showed a meaningful HbA1c drop (0.54%), but cannot separate biotin's contribution from chromium's. The honest read: biotin is a minor adjunct at best, not a glycemic intervention.
Most positive data is in poorly controlled diabetes. In well-controlled or non-diabetic adults, the effect approaches zero. Not a substitute for any first-line diabetes medication.
Chromium picolinate plus biotin in poorly controlled type 2 diabetes
positive · RCT
Albarracin et al., 2008, Diabetes/Metabolism Research and Reviewsn=447447 adults with poorly controlled type 2 diabetes randomized to chromium-plus-biotin combination versus placebo for 90 days. HbA1c dropped 0.54% on the combination versus placebo — modestly clinically meaningful. Effect was largest in patients with baseline HbA1c ≥ 10%.
Combination product — cannot isolate biotin's contribution from chromium's. Chromium has its own evidence base in glycemic control.
Biotin for glycemic control in type 2 diabetes — meta-analysis
mixed · Meta-analysis
Influence of biotin intervention on glycemic control... Frontiers in Nutrition, 2022n=445Pooled 5 RCTs with 445 adults with type 2 diabetes. Biotin supplementation modestly reduced fasting glucose, total cholesterol, and triglycerides. No significant effect on HbA1c, insulin, or LDL. Effect sizes are small and the evidence base is thin.
Small total sample. Mostly co-formulated with chromium. Biotin alone is not a glycemic-control strategy at clinically meaningful magnitude.
Pregnancy and fetal development
Mechanism
Biotin status declines modestly in pregnancy. Severe biotin deficiency in animal models is teratogenic. Translating to humans, marginal biotin deficiency may be more common than appreciated in pregnancy.
Pregnancy creates a real but modest increase in biotin requirement, and prenatal vitamins routinely include biotin. Whether supplemental biotin beyond a standard prenatal benefits the fetus has not been tested in randomized trials. The animal teratogenicity data is the main reason 'do not be biotin-deficient in pregnancy' is the consensus, not 'take extra biotin to support pregnancy.'
Take a prenatal vitamin. Do not separately mega-dose biotin in pregnancy — high doses introduce lab-interference risk that can complicate prenatal monitoring.
Hair growth and thickness
Mechanism
Biotin is a cofactor for carboxylase enzymes in fatty-acid synthesis and amino-acid metabolism. Deficiency disrupts keratin production and causes hair loss. The non-deficient case is mechanistically harder to defend.
There is no randomized trial showing biotin grows hair in non-deficient adults. The 2017 Patel systematic review is unambiguous — every published case of biotin-driven hair improvement was in someone with documented underlying deficiency or a rare biotin-metabolism disorder. The Viviscal-style trials use multi-ingredient formulas that contain biotin alongside marine proteins, vitamin C, and other actives, and cannot isolate biotin's contribution.
Defensible only in documented biotin deficiency, certain genetic disorders (biotinidase deficiency, biotin-thiamine-responsive basal ganglia disease), or as part of a multi-ingredient formula whose efficacy is not driven by biotin specifically. Not defensible for general 'hair, skin, and nails' supplementation in healthy adults.
Systematic review of biotin for hair loss
mixed · Systematic review
Patel, Swink, Castelo-Soccio, 2017, Skin Appendage Disordersn=18Comprehensive review of every published case of biotin for hair and nail conditions. Found 18 cases reporting improvement — and in every single one, the patient had a documented underlying deficiency or biotin-metabolism disorder. The authors' conclusion: 'no high-quality evidence supporting biotin supplementation for hair growth in healthy, non-deficient individuals.'
This is the headline finding for the entire biotin-for-hair industry. Improvement in deficient individuals does not justify supplementation in the non-deficient — yet the marketing routinely conflates the two.
Marine protein complex with biotin for hair thinning
positive · RCT
Ablon, 2012, Journal of Drugs in Dermatologyn=60Industry-funded60 women with hair thinning randomized to a marine-protein-plus-biotin formula versus placebo. Active arm increased terminal hair counts. Listed because it is one of the few RCTs in the area — but the active product is a multi-ingredient supplement and the biotin contribution cannot be isolated.
Cannot attribute the effect to biotin. The marine protein complex is the headline ingredient, not biotin. Manufacturer-funded.
Skin and dermatologic health
Mechanism
Biotin deficiency causes a characteristic perioral dermatitis and seborrheic-style scaling. Repletion fixes deficiency dermatitis. The non-deficient skin case is essentially mechanistic only.
Biotin deficiency produces real skin symptoms — periorificial scaling, hair loss, conjunctivitis. Repletion in deficient adults clears them. There is no controlled trial showing biotin supplementation improves skin in non-deficient adults. The 'glow' and 'clear skin' marketing is unsupported.
Genuine deficiency is rare in adults eating any reasonable mixed diet. Risk groups: long-term raw-egg-white consumption, prolonged total parenteral nutrition without biotin, certain anti-seizure medications, and specific genetic disorders.
Systematic review of biotin for hair loss
mixed · Systematic review
Patel, Swink, Castelo-Soccio, 2017, Skin Appendage Disordersn=18Comprehensive review of every published case of biotin for hair and nail conditions. Found 18 cases reporting improvement — and in every single one, the patient had a documented underlying deficiency or biotin-metabolism disorder. The authors' conclusion: 'no high-quality evidence supporting biotin supplementation for hair growth in healthy, non-deficient individuals.'
This is the headline finding for the entire biotin-for-hair industry. Improvement in deficient individuals does not justify supplementation in the non-deficient — yet the marketing routinely conflates the two.
Energy metabolism
Mechanism
Biotin is a cofactor for four carboxylase enzymes central to fatty-acid synthesis, gluconeogenesis, and amino-acid breakdown. Deficiency impairs cellular energy economy.
The mechanistic story is sound. The clinical trial data does not exist. There is no controlled trial showing biotin supplementation increases energy or reduces fatigue in non-deficient adults. Repletion in genuine deficiency restores normal function; supplementation above adequate intake does nothing in trials.
Helps people who are deficient. Does nothing extra for those who are not — which is almost everyone.
Honest-evidence ledger — 1 trial that didn’t move the needle
Surfacing failed trials alongside the positive evidence. Leaving them out would be marketing, not science.
SPI2 — high-dose pharmaceutical-grade biotin in progressive MS
negative · RCT
Cree, Tourbah et al., 2020, Lancet Neurologyn=642Phase 3 randomized trial of 642 progressive MS patients on 300 mg/day pharmaceutical biotin versus placebo across 13 countries. 12% of biotin patients met the disability-improvement endpoint versus 9% on placebo — not statistically significant. Earlier promising pilot data did not replicate at scale.
MD1003 had a small pilot (Sedel 2015) suggesting benefit. The properly powered phase 3 trial closed the door. Ultra-high-dose biotin is not an MS treatment, and the lab-interference risk made the failure costlier.
4 forms of Vitamin B7 compared
D-Biotin
Well absorbed orally; bioavailability close to 100% at typical supplement doses
Best forGeneric biotin supplementationThe naturally occurring biologically active form. Synthetic and natural D-biotin are identical molecules. There is no meaningful biotin-form premium worth paying for.
Biotin in a multivitamin or B-complex
Well absorbed
Best forGeneral nutrient insurance — biotin is not the headline ingredient in this formatDoses in standard multivitamins (typically 30–300 µg) are physiologically reasonable. Doses in 'hair-skin-nails' specialty products are often 5,000–10,000 µg — pharmacological levels that introduce lab-interference risk for no proven benefit.
Biotin gummies (5,000–10,000 µg)
Well absorbed
Best forMarketed for hair-skin-nails growth; this is the worst use caseThe single most over-marketed format in the supplement aisle. Pharmacological doses of biotin in candy-form for an indication (hair growth in non-deficient adults) the evidence does not support. Adds the lab-interference risk on top.
MD1003
Pharmaceutical-grade biotin (MD1003)
High oral absorption at extreme doses
Best forTested at 300 mg/day in progressive MS — failed in phase 3Not commercially available as a consumer supplement. Listed because the 100-mg-three-times-daily dose tested in MD1003 trials demonstrated the lab-interference problem at scale and ultimately failed its primary endpoint. A reminder that high-dose biotin has clinical baggage.
Are you deficient? Symptoms, risk groups, lab tests
True biotin deficiency is rare. Adequate Intake (AI) is 30 µg/day in adults — easily met by a typical mixed diet, since biotin is widespread in eggs, nuts, seeds, organ meats, salmon, and many vegetables. Marginal deficiency may be more common in pregnancy, in long-term anti-seizure medication users, and in people consuming large quantities of raw egg whites.
Common symptoms
- Thinning hair, often with depigmentation
- Scaly red rash around eyes, nose, mouth, and genitals
- Conjunctivitis
- Brittle nails
- Depression, lethargy, hallucinations in severe cases
- Numbness or tingling in hands and feet
- Loss of body hair in advanced deficiency
- Seizures (in genetic biotinidase deficiency)
- Failure to thrive in infants with inherited disorders
- Decreased immune function
Who is at risk
Long-term raw egg white consumers
Raw egg white contains avidin, a protein that binds biotin and prevents absorption. Cooking denatures avidin. The classic cause of acquired biotin deficiency — practically rare today.
e.g. phenytoin, carbamazepine, phenobarbital, primidone, valproate
Long-term anticonvulsant users
Several older anti-seizure medications increase biotin catabolism and may reduce intestinal absorption. Long-term users can develop marginal deficiency.
People with biotinidase deficiency
Rare autosomal recessive disorder identified on US newborn screening. Prevents recycling of biotin from biocytin. Treated with lifelong oral biotin (5–20 mg/day).
Pregnancy and breastfeeding
Biotin catabolism increases during pregnancy. Marginal deficiency markers (elevated 3-hydroxyisovaleric acid) appear in roughly half of healthy pregnancies. Standard prenatal vitamins cover this.
Long-term parenteral nutrition without biotin supplementation
TPN historically did not contain biotin; modern formulations do. Older case reports of TPN-induced deficiency are why.
Heavy alcohol use
Alcohol impairs biotin absorption and is often paired with poor dietary intake.
Crohn's disease, short bowel syndrome
Severe small-bowel disease impairs absorption. Modest risk relative to other B vitamins.
Smokers (women)
Smoking accelerates biotin catabolism in women in some studies. Effect is small.
Lab markers
Serum biotin
Not routinely available and not a reliable single marker. True deficiency is more often diagnosed clinically or via 3-hydroxyisovaleric acid in urine.
Better:Urinary 3-hydroxyisovaleric acid, Serum biotinidase activity (for genetic disorder)
- Reference range (varies by lab)
- Typically 200–500 ng/L
Side effects and drug interactions
Side effects
Lab assay interference
Severe · Risk emerges at ≥5 mg/day; severe at ≥10 mg/day; ultra-high MD1003 doses (300 mg/day) cause global interference
The dominant biotin safety issue. High-dose biotin (≥5 mg/day) interferes with streptavidin-biotin immunoassays, causing falsely elevated or suppressed results on TSH, free T4, troponin, hCG, parathyroid hormone, and many hormone and tumor markers. At least one death from missed heart attack has been reported to the FDA.
Acne flares
Uncommon
Case reports and dermatology observation suggest high-dose biotin (often combined with B5) may worsen acne in some adults via Cutibacterium-acne interactions.
Mild GI upset
Uncommon
Nausea or stomach discomfort at very high doses. Uncommon at typical supplement levels.
Allergic reactions
Rare
Rare reports of skin rash or hypersensitivity.
Drug interactions
Other
thyroid function tests (TSH, free T4, free T3)Biotin interferes with streptavidin-biotin immunoassays used in many thyroid panels. Direction of interference depends on assay format — can produce a 'fake hyperthyroid' or 'fake hypothyroid' picture.
Stop biotin at least 72 hours before thyroid testing, or alert the lab. Several published cases of misdiagnosed Graves' disease leading to inappropriate antithyroid treatment have been traced to biotin supplementation.
Other
troponin assays (heart attack workup)Biotin can falsely lower troponin results, masking a real myocardial infarction.
If you take high-dose biotin and present with chest pain, tell the ER. The FDA has issued specific safety communications on this risk.
Other
hCG (pregnancy testing)hormone panels (estradiol, testosterone, cortisol)Same streptavidin-biotin assay interference. Can cause false-positive or false-negative hCG, distorted reproductive hormone values, and erroneous endocrine workups.
Stop biotin at least 72 hours before relevant testing. Critical in fertility workups and prenatal care.
Reduces nutrient status
phenytoincarbamazepinephenobarbitalprimidoneOlder anticonvulsants accelerate biotin catabolism and may reduce absorption. Long-term users can develop marginal deficiency.
Consider biotin supplementation at modest doses (300–1000 µg/day) in long-term anticonvulsant users; monitor for any planned lab work.
Other
raw egg white (dietary)Avidin in raw egg white binds biotin and prevents absorption. Denatured by cooking.
Routine raw-egg-white consumption (some bodybuilding and traditional practices) can produce frank biotin deficiency. Cook the eggs.
Other critical caveats
- Biotin does not grow hair in non-deficient adults. There is no randomized trial demonstrating it. The Patel 2017 systematic review documented every published case of biotin-driven hair improvement and found that all involved underlying deficiency or rare biotin-metabolism disorders. The 'biotin for hair' industry is selling a story the evidence does not support.
- High-dose biotin (≥5 mg/day) interferes with critical lab tests including thyroid panels, troponin, pregnancy tests, and hormone assays. Stop biotin at least 72 hours before any blood work, or tell your doctor and the lab. The FDA has issued specific safety communications including a death from a missed heart attack attributed to biotin-induced false-low troponin.
- Pharmaceutical-grade biotin (MD1003, 300 mg/day) failed in a phase 3 progressive MS trial of 642 patients. Even at 100,000-fold the daily requirement, biotin does not modify MS progression. Closes the door on the high-dose-MS hypothesis.
- Most 'hair-skin-nails' supplements contain pharmacological doses of biotin (5,000–10,000 µg, or 167–333× the AI) for an indication the evidence does not support, with a real lab-interference risk attached. Skip these for the indication and pick a multivitamin or specialist product whose evidence base actually exists.
- Genuine biotin-responsive conditions exist — biotinidase deficiency, holocarboxylase synthetase deficiency, biotin-thiamine-responsive basal ganglia disease — and treatment is high-dose lifelong oral biotin under specialist care. These are rare genetic disorders, not the indications driving the consumer market.
Frequently asked
Will biotin make my hair grow?
Almost certainly not, unless you are biotin-deficient — and almost no one is. The 2017 Patel systematic review checked every published case of biotin-driven hair improvement and found that every single one involved an underlying biotin deficiency or rare metabolic disorder. There is no randomized trial showing biotin grows hair in healthy non-deficient adults. The 'biotin for hair growth' industry runs on marketing extrapolated from rare genuine deficiency states to a population that almost never has the condition.Is biotin safe to take?
At typical low-dose multivitamin levels (30–300 µg) it is safe and well tolerated. The serious safety issue is at supplement doses of 5,000–10,000 µg (5–10 mg) that pack-of-gummies marketing pushes, where biotin interferes with streptavidin-biotin immunoassays — thyroid panels, troponin, hCG, hormone tests. The FDA has issued specific safety communications. At least one death from missed heart attack has been reported. Stop biotin 72 hours before any lab work, or tell your doctor.How much biotin do I need?
The Adequate Intake is 30 µg/day for adults. A typical mixed diet provides this easily — eggs, nuts, seeds, organ meats, salmon, sweet potatoes, and many vegetables are biotin sources. Most adults exceed the AI from food alone. There is no established upper limit because biotin has no known dose-related toxicity, but doses ≥5 mg/day introduce the lab-interference issue independent of toxicity.Will biotin help my brittle nails?
Maybe, with a long timeline. Two open-label studies in the 1990s (Colombo, Hochman) reported improvement in nail thickness or subjective firmness on 2.5 mg/day biotin over 6+ months in adults with genuinely brittle, splitting nails. Neither study had a placebo control, so the evidence is methodologically thin — but this is the strongest case biotin has outside frank deficiency. Reasonable to try for 6 months in documented brittle nail syndrome. Stop before any lab work.Why is biotin in every hair-skin-nails supplement?
Marketing inertia and the cheap-vs-effective tradeoff. Biotin is inexpensive, has a known role in keratin production (the mechanism is mechanistically plausible), and produces a clean story — even though the human evidence in non-deficient adults is essentially absent. Once the category formed, every brand had to include biotin to compete. The result: a billion-dollar segment built on a study population (deficient individuals) that bears no resemblance to the consumer base.
References
- 01NIH Office of Dietary Supplements — Biotin Health Professional Fact Sheet
- 02FDA Safety Communication — Biotin Interference with Lab Tests
- 03Patel et al., 2017 — A Review of the Use of Biotin for Hair Loss
Last reviewed2026-05-07